SCHEMBL8245334

SCHEMBL8245334

CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(C2=NNCC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
ROCK2 O75116 8/20 0.34
ROCK1 Q13464 1/20 0.34
RAB9A P51151 2/20 0.33
KDR P35968 2/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
PDE3B Q13370 1/20 0.33
FLT3 P36888 2/20 0.33
AAK1 Q2M2I8 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328090 0.83 ALDH1A1 (0.46) NISCHROCK2ROCK1KDRPOLB
SCHEMBL8235455 0.81 ROCK1 (0.32) ROCK1RAB9AKDRNPC1PDE3B
Trifluoroacetic Acid SCHEMBL3328120 0.76 KDR (0.40) ROCK2ROCK1KDRPOLBFLT3
SCHEMBL3326596 0.74 NPC1 (0.47) RAB9AKDRNPC1POLBFLT3
SCHEMBL8215800 0.72 TAAR1 (0.63) TAAR1RAB9ANPC1POLBSMN1; SMN2
SCHEMBL8218265 0.70 ROCK1 (0.43) TAAR1ROCK2ROCK1RAB9ANPC1
SCHEMBL3324137 0.69 KIF11 (0.47) ROCK2ROCK1KDRPOLBSMN1; SMN2
SCHEMBL10474308 0.68 KCNH2 (0.54) RAB9ANPC1PDE3BSMN1; SMN2MAPT
SCHEMBL8207992 0.68 KIF11 (0.58) RAB9ANPC1HTTALDH1A1MAPT
SCHEMBL16356391 0.68 MAPT (0.54) L3MBTL1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064732-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2007-06-07 WO disclosed